EC Number |
Inhibitors |
Structure |
---|
4.2.2.1 | (13Z)-docos-13-enoic acid |
strong inhibition |
|
4.2.2.1 | (13Z)-docos-13-enoic acid |
weak inhibition |
|
4.2.2.1 | (25S)-(+)-12alpha-hydroxy-3alpha-methylcarboxyacetate-24-methyllanosta-8,24(31)-diene-26-oic acid |
from Piptoporus betulinus inhibiting bacterial hyaluronate lyase, structure determination by NMR, IC50 is 0.0035 mM |
|
4.2.2.1 | (2E)-1-furan-2-yl-3-(4-nitrophenyl)prop-2-en-1-one |
IC50 at enzyme optimum pH 5.0 is 0.31 mM, and 0.16 mM at physiological pH 7.4 |
|
4.2.2.1 | (3-chlorophenyl)(2-thioxo-1H-benzo[d]imidazol-1-yl)methanone |
- |
|
4.2.2.1 | (E)-3-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)prop-2-en-1-one |
36% inhibition |
|
4.2.2.1 | 1,10-phenanthroline |
5 mM, 75% residual activity |
|
4.2.2.1 | 1,3-benzoxazole-2(3H)-thione |
- |
|
4.2.2.1 | 1,3-diacetyl-1H-benzo[d]imidazol-2(3H)-one |
10% inhibition |
|
4.2.2.1 | 1,3-diacetyl-benzimidazole-2-thione |
IC50 at enzyme optimum pH 5.0 is 0.16 mM, and 0.005 mM at physiological pH 7.4 |
|